Category Archives: Prescription Drugs

More and better information can enhance patient care

With Congress intensely focused on big decisions involving health reform legislation, it’s easy to miss other initiatives that are quietly moving through Congress which could make a major contribution to achieving the goals of health reform One example is a measure offered by Rep. Morgan Griffith (R-VA) that would open the lines of communication between […]

Read More

New Taxes Won’t Lower Drug Prices

Prescription drug prices continue to be a hot political issue, with the Trump administration preparing to release an action plan as soon as repeal and replace legislation clears Congress. Mick Mulvaney, who heads the White House budget office and is participating in the talks, floated an idea last week that should quickly be crossed off […]

Read More

Far-Reaching Medicare Part B Changes Violate Separation Of Powers — And With CBO’s Blessing

Members of Congress expressed outrage at the Congressional Budget Office during a recent House hearing for assuming that sweeping, untested changes to Medicare will save $34 billion “even before you know what the project is,” Rep. Scott Garrett (R-NJ) said. “There is no cost-benefit analysis, there is no testing done, you don’t even know what […]

Read More

Competition in Medicare Advantage, Part D, and “Extra Help”/ Working together for seniors and taxpayers

Seniors are beginning to get fliers in the mail alerting them to the upcoming open season for enrollment in Medicare Advantage and Medicare Part D prescription drug plans.  Both programs rely on competition and consumer choice to increase options and hold down costs for seniors.  Open season begins October 15 for those planning to enroll […]

Read More

More Competition is the Best Cure

The most interesting thing about the PR disaster involving Mylan’s life-saving EpiPen is probably the least discussed—namely that drugs don’t cost what people think they do. Faced with a barrage of criticism for EpiPen price hikes, from about $100 in 2009 to more than $600 today, Mylan’s CEO Heather Bresch explains that her company gets less than […]

Read More